Our blog

Pallas vs Sprout: GLP-1 Telehealth Compared

Reading time
6 min read
Topic
Cost & access
Published

A comparison of Pallas Health and Sprout (Sprout Health) for GLP-1 weight loss — low advertised entry prices versus published renewal terms, refund fees, state coverage, and what to verify in 2026.

Sprout (Sprout Health) is one of the newer entrants in compounded GLP-1 telehealth, advertising low entry prices, fast prescribing, and a flat-price-at-every-dose pledge. Pallas Health shares several of those traits — no membership, flat dosing, free shipping — so this comparison is mostly about what's published versus what isn't, and the terms that apply when plans change.

Pricing on both sides changes often; figures reflect each platform's published pricing as of August 2026 — confirm current numbers on both sites before signing up.

The three differences that matter most

  1. Published renewal terms. Sprout advertises compounded semaglutide "starting at $149/month" and tirzepatide at $199/month — but its ongoing renewal prices aren't published on the site; they appear at checkout. Pallas prints the whole arc in one sentence on every surface: $139 first month, then $199 every 4 weeks, charged once a clinician prescribes. Cancel anytime. Whichever platform you choose, get the renewal number in writing before you pay.
  2. The refund mechanics. Per Sprout's published policy, refunds are full before a provider reviews your intake; after review but before pharmacy fulfillment, a flat $50 clinical review fee is withheld; after fulfillment, orders are non-refundable — and cancellation needs 48 hours' notice before billing. Pallas charges nothing until a clinician prescribes, so there is no fee to withhold, and its plans cancel anytime.
  3. State coverage. Per its own terms, Sprout doesn't serve Alabama, Arkansas, Mississippi, Louisiana, California, or North Dakota. Pallas serves all 50 states plus DC.

About compounded medications

Compounded medications are prepared on a per-patient basis by US-licensed compounding pharmacies, regulated under federal law (FDCA §503A) and by state boards of pharmacy. A licensed clinician decides whether a compounded preparation — for example, a dose level or a formulation a brand-name product doesn't offer — is appropriate for you.

Pallas offers both FDA-approved and compounded medications. Compounded medications are not FDA-approved and are not generic versions of brand-name drugs. Eligibility and treatment are determined by a US-licensed clinician; results vary. Private pay only (no insurance). Operated by Brentmoor, Inc.

Quick comparison

Pallas HealthSprout
Compounded semaglutide injectionYes — one all-in price, renewal stated up frontYes — "starting at $149/mo"; renewal shown at checkout
Compounded tirzepatide injectionYes — one all-in priceYes — "starting at $199/mo"; renewal shown at checkout
FDA-approved brand (Wegovy®, Zepbound®)Yes — $499 first month, then from $599/mo, cash-payYes — Wegovy® $1,799/mo, Zepbound® $1,999/mo
Membership feeNoneNone
Price changes as your dose increasesNo — flat at every doseNo, per their pledge
If a clinician doesn't prescribeNothing chargedFull refund before review; $50 fee withheld after review
CancellationAnytime, self-serve in portal48-hour notice before billing
States servedAll 50 + DC44 states (excludes AL, AR, MS, LA, CA, ND)
Companion appFree on iOS and Android, no subscriptionNot offered
Year founded20262025

What Sprout does well

Low advertised entry pricing. Sprout's $149 semaglutide and $199 tirzepatide entry prices — with promo codes running on top — are among the lower advertised numbers in the category, with free shipping and no membership fee, and it pledges that your price won't rise as your dose does.

Fast prescribing. Sprout advertises clinician review and, when appropriate, a prescription within 24–48 hours of its quiz-based intake, through a physician-only clinical network.

What Pallas does differently

Everything on the label. Pallas publishes the full pricing arc — intro, renewal amount, interval, and monthly average — in one sentence on every surface: $139 first month, then $199 every 4 weeks, charged once a clinician prescribes. Cancel anytime. Tirzepatide is $179 first month, then $299 every 4 weeks, charged once a clinician prescribes. Cancel anytime. No checkout reveal, no fee schedule to discover later. Both plans — compounded semaglutide and compounded tirzepatide — are weekly injections with clinician care included.

Charged only if prescribed. Nothing is charged until a clinician prescribes, so there is no $50 fee to withhold. Cancel anytime, no notice window, self-serve in the portal.

Every state, both tiers, verifiable. All 50 states plus DC, brand-name pens dispensed cash-pay at $499 for the first month and then from $599/month (roughly $1,200–1,400/month below Sprout's listed brand prices), and LegitScript Healthcare Merchant Certification you can confirm in LegitScript's public database. The free Pallas companion app (iOS and Android) covers protein, steps, weight trend, and dose reminders.

Who should pick which

Sprout may fit if:

  • Its advertised entry price plus a current promo code beats what you've found elsewhere — after you've confirmed the renewal price at checkout
  • You live in one of its 44 covered states and want a quiz-fast intake

Pallas is probably the better fit if:

  • You want the renewal price published before you start, not revealed at checkout
  • You want nothing charged unless a clinician prescribes, with no review fee withheld
  • You live in Alabama, Arkansas, Mississippi, Louisiana, California, or North Dakota — or want DC coverage
  • You may want brand-name medication — Pallas's brand tier is substantially cheaper
  • You want a self-serve portal

Switching between them

Bring your medication name, current dose, and titration history, and mind Sprout's 48-hour billing notice when timing a switch. A Pallas clinician picks up from your current dose — no restart of titration unless you've been off medication for more than four weeks. For the clinical side of choosing between molecules, see semaglutide vs tirzepatide.


Bottom line: Sprout advertises sharp entry prices with a flat-dose pledge and fast prescribing — with renewal prices revealed at checkout, a $50 fee withheld on post-review refunds, and six states unserved. Pallas publishes the entire price arc up front, charges nothing until a clinician prescribes, serves every state, and dispenses brand-name medication at far lower cash prices. If an entry-price promo decides it for you, confirm Sprout's renewal number first; if published terms and exit flexibility decide it, that's what Pallas is built on.

Frequently asked questions

Sprout (Sprout Health Partners) is a real, young telehealth company — incorporated in early 2025, based in Encinitas, California, prescribing through a physician-only clinical network. Facts worth knowing before enrolling: in September 2025 the FDA issued Sprout a warning letter regarding marketing claims for its compounded GLP-1s (public on fda.gov); as of August 2026 its Better Business Bureau profile shows an F rating; and its renewal prices are shown only at checkout. Verify any platform in LegitScript's public database and get the renewal rate in writing.

Sprout advertises "starting at $149/month" (tirzepatide from $199/month) with promo codes on top — but the ongoing renewal price isn't published on its site; it appears at checkout. Pallas publishes the whole arc: $139 first month, then $199 every 4 weeks, charged once a clinician prescribes. Cancel anytime.

Per its own terms as of August 2026, Sprout doesn't serve Alabama, Arkansas, Mississippi, Louisiana, California, or North Dakota. Pallas serves all 50 states plus Washington, D.C.

Per its published policy: a full refund before a provider reviews your intake; after review but before pharmacy fulfillment, a flat $50 clinical review fee is withheld; after fulfillment, orders are non-refundable — with 48 hours' notice required before billing to cancel. Pallas charges nothing until a clinician prescribes, so there is no fee to withhold, and you can cancel anytime.

Yes. Save your medication name, current dose, and titration history, and mind Sprout's 48-hour billing notice when timing the switch. A Pallas clinician picks up from your current dose — no restart of titration unless you've been off medication for more than four weeks.

Related articles

References

Platform pricing and program details reflect each company's publicly published terms as of August 2026 and change frequently — confirm current numbers on each platform's site before enrolling. The regulatory basis for compounded preparations is summarized by the FDA.

  1. Sprout Health. Pricing and refund policy, as published August 2026.
  2. U.S. Food and Drug Administration. Warning letter to Sprout Health Partners LLC (MARCS-CMS 715879). September 9, 2025.
  3. U.S. Food and Drug Administration. FDA Clarifies Policies for Compounders as National GLP-1 Supply Begins to Stabilize. 2025.